These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8685230)
1. Growth factors and oncogene products in transitional cell carcinoma. Nakanishi K; Kawai T; Suzuki M; Torikata C Mod Pathol; 1996 Mar; 9(3):292-7. PubMed ID: 8685230 [TBL] [Abstract][Full Text] [Related]
2. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients. Gorgoulis VG; Barbatis C; Poulias I; Karameris AM Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract. Nakanishi K; Kawai T; Torikata C Hum Pathol; 1996 Dec; 27(12):1336-40. PubMed ID: 8958308 [TBL] [Abstract][Full Text] [Related]
4. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Raman JD; Sosa RE; Vaughan ED; Scherr DS Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658 [TBL] [Abstract][Full Text] [Related]
5. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract. Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612 [TBL] [Abstract][Full Text] [Related]
6. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma. Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619 [TBL] [Abstract][Full Text] [Related]
7. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome. Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193 [TBL] [Abstract][Full Text] [Related]
8. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877 [TBL] [Abstract][Full Text] [Related]
9. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis. Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma. Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954 [TBL] [Abstract][Full Text] [Related]
12. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract. Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378 [TBL] [Abstract][Full Text] [Related]
13. Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer. Lee SE; Chow NH; Chi YC; Tzai TS; Yang WH; Lin SN Anticancer Res; 1994; 14(3B):1317-24. PubMed ID: 7915094 [TBL] [Abstract][Full Text] [Related]
14. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract. Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044 [TBL] [Abstract][Full Text] [Related]
15. c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized, high-grade transitional cell carcinoma of the bladder. Swanson PE; Frierson HF; Wick MR Mod Pathol; 1992 Sep; 5(5):531-6. PubMed ID: 1364264 [TBL] [Abstract][Full Text] [Related]
16. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers. Novara G; De Marco V; Dalpiaz O; Galfano A; Bouygues V; Gardiman M; Martignoni G; Patard JJ; Artibani W; Ficarra V Int J Urol; 2009 Feb; 16(2):187-91. PubMed ID: 19054165 [TBL] [Abstract][Full Text] [Related]
17. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Fromont G; RouprĂȘt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329 [TBL] [Abstract][Full Text] [Related]
18. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma. Lager DJ; Slagel DD; Palechek PL Mod Pathol; 1994 Jun; 7(5):544-8. PubMed ID: 7937720 [TBL] [Abstract][Full Text] [Related]
20. Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer. Lipponen PK J Pathol; 1995 Feb; 175(2):203-10. PubMed ID: 7738716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]